Aggresome formation by anti-Ras intracellular scFv fragments: The fate of the antigen-antibody complex

European Journal of Biochemistry

Volumn 268, Issue 2, 2001, Pages 268-277

  Cardinale, Alessio ^a   Filesi, Ilaria ^a   Biocca, Silvia ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Aggresome; Intracellular antibodies; Proteasome; ScFv fragment; Ubiquitin

Indexed keywords

NOCODAZOLE; PEPTIDE FRAGMENT; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN P21; RAS PROTEIN; RAS PROTEIN ANTIBODY; SINGLE CHAIN VARIABLE FRAGMENT; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGEN FUNCTION; ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; GENETIC TRANSFECTION; MICROTUBULE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REACTION ANALYSIS;

EID: 0034817979     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2001.01876.x     Document Type: Article

References (41)

1. Expression and targeting of intracellular antibodies in mammalian cells
2. Intracellular antibodies: Development and therapeutic potential
3. Intracellular expression of anti-p21ras single-chain Fv fragments inhibits meiotic maturation of Xenopus oocytes
4. Intracellular immunization with cytosolic recombinant antibodies
5. Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack
6. Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev. single-chain antibody
7. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies
8. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody
9. The selection of intracellular antibodies
10. Macromolecular crowding: Biochemical, biophysical and physiological consequences
11. Protein folding in the cell: Competing models of chaperonin function
12. Protein folding and misfolding inside and outside the cell
13. Aggresomes: A cellular response to misfolded proteins
14. Dynamic association of proteasomal machinery with the centrosome
15. Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera
16. Increasing complexity of Ras signaling
17. The mode of action of Y13-259 scFv fragment intracellularly expressed in mammalian cells
18. Diverting a protein from its cellular location by intracellular antibodies. The case of p21Ras
19. Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression
20. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library
21. Degradation of CFTR by ubiquitin-proteasome pathway
22. Targeting vectors for intracellular immunisation
23. Isolation of monoclonal antibodies specific for humen c-myc proto-oncogene product
24. Lactacystin, proteasome function and cell fate
25. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lacta-cystin
26. The 26 proteasome: A molecular machine designed for controlled proteolysis
27. Functions of the proteasome: The lysis at the end of the tunnel
28. Selective protein degradation: A journey's within the proteasome
29. The ubiquitin-proteasome pathway: On protein death and cell life
30. Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs
31. Structural dynamics of green fluorescent protein alone and fused with a single chain Fv protein
32. Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria
33. Mutations and off-pathway aggregation of proteins
34. Aggresomes and Russell bodies: Symptoms of cellular indigestion?
35. Substrate targeting in the ubiquitin system
36. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes
37. Characterization of a new intrabody directed against the N-terminal region of human p53
38. Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity
39. Dislodgment and accelerated degradation of Ras
40. Intracellular localization of proteasomal degradation of a viral antigen